7890-full
sunset15
Sex: F
Data Quality: 2 stars
MS: 7 yrs
Type: Relapsing-Remitting
Relapse: Moderate
Sensation: Mild
Overall: Mild
Cognition: moderate
Vision: none
Speech: none
Swallowing: none
Upper limb: moderate
Walking: moderate
sunset15
Female, 41 years
Huntersville, NC
Primary Condition
MS and 4 more ▼
Type
Relapsing-Remitting
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

sunset15's Dalfampridine (4-AP extended release) is for:

sunset15 has not reported any side effects for Dalfampridine (4-AP extended release).

sunset15's Dalfampridine (4-AP extended release) History (Stopped)
sunset15 has not added a dosage.
Stopped Did not seem to work Feb 01, 2012
Stopped Did not seem to work Feb 01, 2012
Stopped Did not seem to work Feb 01, 2012
Stopped Did not seem to work Feb 01, 2012
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Improve mobility Perceived effectiveness Walking problems Perceived effectiveness Side Effects Adherence Burden
Feb 01, 2012   ? ? ? NoneNoneNoneNone AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all

About Dalfampridine (4-AP extended release) (Prescription Drug)

Dalfampridine, is an extended release formulation of 4-aminopyridine or 4-AP. It is a potassium channel blocker that is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). Dalfampridine was previously called Fampridine-SR during clinical trials.

Learn more about Dalfampridine (4-AP extended release) in our Dalfampridine (4-AP extended release) Community Report.

Back to sunset15's Profile